EVEXIA PRACTICE MANAGEMENT SOLUTIONS

Welcome to the Evexia Diagnostics COVID-19 Repository Page.

While the global health crisis concerning the SARS-CoV-2 pandemic continues to unfold, Evexia’s focus and commitment to offering high-quality, state-of-the-art testing at affordable prices are becoming increasingly vital. Our current goal is to increase the availability of fast and reliable COVID-19 testing to help mitigate the current spread of the virus. We also recognize that there is a lack of proper guidance on what testing is most appropriate. As a result, we have created this resource dedicated to providing easy access to insightful information, cost-effective and reliable testing options, as well as recommendations for nutraceutical support.

Order COVID-19 Testing

Review our full offering of the most advanced
COVID-19 testing for every stage of the virus.

Learn more about COVID-19

Learn about the latest COVID-19 facts and testing.

COVID-19 TESTING GUIDANCE

COVID-19 TESTING INTERACTIVE GUIDE

To find the COVID-19 testing that is right for your patients:

1. Review the 3 questions to the right and click on the one that applies to your patient.

2. Continue to answer the Yes and No questions until you are supplied with the proper COVID-19 test that is is optimal for your patient.

3. Click on the answer to be taken to the proper testing where you may learn more and begin ordering.

We also provide this helpful testing guidance information in a convenient pdf document, click here to view or download.

Available SARS CoV-2 (COVID-19) Testing

Evexia Diagnostics now offers COVID-19 testing options for ALL of our clients. Each of our trusted laboratory partners is CLIA-Certified and all testing is performed at High-Complexity laboratory facilities.

For additional clarification regarding the best testing option for your patients, please utilize our COVID-19 Interactive Testing Guidance, located here. 

Antibody Testing

To learn more about Antibody Testing – Click Here  •  To learn more about Antibodies – Click Here

SARS CoV-2 IgG/IgM Antibody Test

PCR Testing

SARS CoV-2 Respiratory
PCR Test

SARS CoV-2 
Stool PCR Test

COVID-19 Antibody Testing

  • NOT A DIAGNOSTIC TEST FOR CURRENT COVID-19 INFECTION
  • Detects body’s immune response to COVID-19 by measuring specific antibodies associated with COVID-19 (SARS-CoV-2)
  • Any positive results should be confirmed using the COVID-19 PCR Test.
  • Follow-up testing with the COVID-19 PCR Test should also be considered to rule out infection in individuals with a negative COVID-19 Antibody Test who exhibit symptoms of COVID-19
  • Blood draw required
Please note that negative results do not rule out SARS-CoV-2 infection. Results from the COVID-19 Antibody Test should not be used as the sole basis for diagnosis or exclusion of a SARS-CoV-2 infection. This COVID-19 antibody test is based on a unique fragment of the nucleoprotein from COVID-19 (SARS-Cov-2). Antibodies, IgM and IgG, generated against this fragment have been demonstrated NOT to cross-react with other viruses, including other coronavirus strains. Follow-up testing with the COVID-19 PCR test should be considered to rule out infection in individuals with negative serological results who exhibit symptoms of COVID-19.

COVID-19 Antibody Testing is available to all Evexia clients, including non-licensed clinicians. For all non-licensed client orders, a $15 physician network fee will apply and our phlebotomy network must be utilized for sample collection and shipping.

ANTIBODY TYPES:

IgA –

  • IgA antibodies are found in saliva, tears, and blood.
  • IgA antibodies protect bodily surfaces that are exposed to outside foreign substances and are found in areas of the body such the nose, breathing passages, digestive tract, ears, and eyes.
  • About 10% to 15% of the antibodies present in the body are IgA antibodies.
  • A small number of people do not make IgA antibodies.

IgG –

  • IgG antibodies are found in all body fluids.
  • IgG antibodies are the smallest but most common antibody (75% to 80%).
  • IgG antibodies are very important in fighting bacterial and viral infections.
  • IgG antibodies are the only type of antibody that can cross the placenta in a pregnant woman to help protect the fetus.

IgM –

  • IgM antibodies are found in blood and lymph fluid and are the first type of antibody made in response to an infection.
  • IgM antibodies also cause other immune system cells to destroy foreign substances.
  • IgM antibodies are the largest antibody and make up about 5% to 10% of all the antibodies in the body.

Evexia Diagnostics does not accept any form of insurance nor do we have the ability to seek third-party reimbursement. We are offering this test as a convenience to our clients and their patients, who may not be able or may choose not to travel to a location where the test can be charged to a third-party. The fees charged by Evexia to our clients for the COVID-19 test are a reflection of our cost related to the acquisition and distribution of the COVID-19 test and supplies. Anyone who is symptomatic and/or who meets the CDC’s guidelines for testing has the option of receiving the test for free, but they would need to locate a testing facility (clinic, drive-thru or hospital) that is able to seek 3rd-party reimbursement and have the testing done there.

LATEST COVID-19 UPDATES

JUNE 4, 2020 -3:00 P.M.
Evexia is excited to announce the addition of a COVID-19 Antibody Reflex Test to our already comprehensive stable of offerings. This new option begins by qualitatively testing serological samples for SARS-CoV-2 total antibodies. If the initial result is confirmed to be positive, the test then automatically reflexes to quantify the presence of both IgG and IgM SARS-CoV-2 antibodies. The reported sensitivity for this test is 100%, and the reported specificity is 99.8%. Reports for all three result components are available within 24 hours.

Click Here – To view our new antibody test.

MAY 7, 2020 - 2:00 P.M.

Evexia Diagnostics is excited to expand our current COVID-19 test offerings to now include a new COVID-19 Antibody A La Carte option. This cost-effective and flexible solution provides testing for individual IgA, IgG, and IgM immunoglobulins or any combination that best suits the needs of your patients. Another added convenience feature is that the IgG option can be collected at over 2000 Patient Service Centers (PSCs) across the country. The IgA and IgM analytes, however, must be collected in office or at the patient’s home through a mobile phlebotomy service. Contact us today to learn more and place your order!

Click Here – To view our new antibody test options.

NOTICE:
Please be aware that due to supply constraints we are not able to offer the nasopharyngeal PCR test until further notice. However, the nasal swab PCR option is still available for order.

Click here >>

APRIL 2, 2020 - 2:00 P.M.

Evexia Diagnostics is pleased to announce the launch of the new COVID-19 PCR Stool Test, which is now available to all Evexia clients! The new COVID-19 PCR Stool Test utilizes a cutting-edge viral RNA qPCR methodology to detect and measure levels of SARS-CoV-2 virus in stool.  The new COVID-19 PCR Stool Test, can be an important clinical tool for clinicians who are monitoring confirmed SARS-CoV-2 patients in order to help prevent transmission of the SARS-CoV-2 virus.

COVID-19 PCR Stool Testing 

Recent studies have demonstrated that SARS-CoV-2 in the stool may be found in up to 53.4% of COVID-19 patients and can be detected in the stool for a period of days to weeks after the initial infection.  Emerging evidence also shows that an intestinal viral infection may play an important role in COVID-19 disease progression and may increase the risk of more severe disease.

This test is important because the detection of SARS-CoV-2 in the stool could be used to prevent fecal-oral transmission.

Please note that the SARS-CoV-2 Stool Analysis is not diagnostic of COVID-19. COVID-19 can only be properly diagnosed and confirmed using the nasopharyngeal COVID-19 PCR Test.

THE EVEXIA WEBINAR SERIES – SPECIAL EDITION

Wayne L. Sodano, DC, DABCI, DACBN, CFMP, CIHP, BCTN
Director of Clinical Support and Education
Evexia Diagnostics

Contributors:
Kevin K. Bodling, DC, DACBN, DABCI
President & Chief Executive Officer
Evexia Diagnostics
Will Blankenship, MD
Chief Medical Officer
Evexia Diagnostics

Evexia Diagnostics is pleased to present “COVID-19: Immune Preparedness Against An Unfolding Pandemic”. This video serves as a follow up to our previous COVID-19 webinar and provides some updated information, but more importantly, offers an in-depth look at avenues to improve immune function and help prevent infection.

Disclaimer: This webinar is for professional educational purposes only. Currently there are no pharmaceutical or natural medicines approved by the FDA to specifically treat COVID-19.

Wayne L. Sodano, DC, DABCI, DACBN, CFMP, CIHP, BCTN
Director of Clinical Support and Education
Evexia Diagnostics

Contributors:
Kevin K. Bodling, DC, DACBN, DABCI
President & Chief Executive Officer
Evexia Diagnostics
Will Blankenship, MD
Chief Medical Officer
Evexia Diagnostics

The underlying importance of a properly functioning immune system is highlighted as global concerns continue to grow regarding the spread of COVID-19 (Coronavirus Disease).  Evexia Diagnostics is proud to offer an educational webinar for you to learn more about the natural avenues and precautionary measures available to help safeguard against infection and to help ensure that your patient’s immune system is able to provide an adequate response to this emerging threat.

Disclaimer: This webinar is for professional educational purposes only. Currently there are no pharmaceutical or natural medicines approved by the FDA to specifically treat COVID-19.

EVEXIA TESTING AND NUTRACEUTICAL RECOMMENDATIONS FOR BUILDING AND SUPPORTING A STRONG IMMUNE SYSTEM

Recommended Evexia Panels

2020 Complete Wellness Panel
    • Apolipoprotein B
    • Bilirubin, Direct
    • Complete Blood Count (CBC) With Differential
    • Comprehensive Metabolic Panel (CMP-14)
    • Cortisol
    • C-Reactive Protein (CRP), High Sensitivity
    • Dehydroepiandrosterone (DHEA) Sulfate
    • Ferritin + Iron + Total Iron-binding Capacity (TIBC)
    • Fibrinogen Activity (Factor I Activity)
    • Gamma-Glutamyl Transferase (GGT)
    • Hemoglobin (Hb) A1c With eAG
    • Homocyst(e)ine
    • Insulin
    • Lactic Acid Dehydrogenase (LD/LDH)
    • Lipid Panel + VLDL + TC/HDL Ratio + LDL/HDL Ratio + CHD Risk
    • Lipoprotein(a)
    • Magnesium
    • Phosphorus
    • Thyroid Profile II, Comprehensive (FTI; T3 Uptake; TSH; T4; T3)
    • Uric Acid
    • Vitamin D, 25-Hydroxy
2020 Comprehensive Wellness Panel
    • Apolipoprotein B
    • Bilirubin, Direct
    • Coenzyme Q10, Total (CoQ10)
    • Complete Blood Count (CBC) With Differential
    • Comprehensive Metabolic Panel (CMP-14)
    • Cortisol
    • C-Reactive Protein (CRP), High Sensitivity
    • Deaminated Gliadin Antibodies, IgA & IgG
    • Dehydroepiandrosterone (DHEA) Sulfate
    • Estradiol (E2)
    • F2-Isoprostane/Creatinine Ratio
    • Ferritin + Iron + Total Iron-binding Capacity (TIBC)
    • Fibrinogen Activity (Factor I Activity)
    • Folate, RBC
    • Gamma-Glutamyl Transferase (GGT)
    • Hemoglobin (Hb) A1c With eAG
    • Homocyst(e)ine
    • Insulin
    • Iodine, Serum or Plasma
    • Lactic Acid Dehydrogenase (LD/LDH)
    • Lipid Panel + VLDL + TC/HDL Ratio + LDL/HDL Ratio + CHD Risk
    • Lipoprotein(a)
    • Magnesium
    • Magnesium, RBC
    • Omega 3 and 6 Fatty Acids
    • Phosphorus
    • Testosterone Profile (Bioactive + Total), LC/MS-MS
    • Thyroid Profile II, Comprehensive (FTI; T3 Uptake; TSH; T4; T3)
    • Uric Acid
    • Urinalysis, Complete with Microscopic Examination
    • Vitamin B12 (Cobalamin)
    • Vitamin D, 25-Hydroxy
    • Zinc, RBC

Recommended Individual Tests

  • Complete Blood Count (CBC) With Differential
  • Comprehensive Metabolic Panel (CMP-14)
  • Cortisol
  • Eosinophil Cationic Protein (ECP) / Ribonuclease 3
  • F2-Isoprostane
  • Glutathione
  • Immunoglobulins, Quantitative, IgA, IgG, IgM
  • Influenza A and B Antibodies
  • Interleukin-02 (IL-2)
  • Mannose-binding Lectin (MBL)
  • Myeloperoxidase (MPO)
  • Natural Killer Cell and Activated T-Cell Profile/IL-2r
  • Neopterin, Urin

 

  • Respiratory Pathogen Profile, Comprehensive, PCR
  • Tumor Necrosis Factor-α
  • Vitamin A (Retinol)
  • Vitamin C (Ascorbic Acid)
  • Vitamin C (With Dilution)
  • Zinc, RBC

Recommended Specialty Tests

  • GDX- ImmunoGenomic Profile
  • GDX- ION Profile
  • GDX- NutrEval
  • GDX- ONE (Optimal Nutritional Evaluation) FMV
  • GDX- Oxidative Stress Analysis 2.0
  • Spectracell- Micronutrient Test

Recommended Evexia Nutraceuticals and Supplements

Currently there are no pharmaceutical or natural medicines approved by the FDA to specifically treat COVID-19​.

Immune Essentials Plus

More information >>

Silver Max

More information >>

Zinc Max

More information >>

Essential Protein BEEF Plus

More information >>

C+Flavinoids

More information >>

Multi Complex Plus

More information >>

Max Antiox Complete

More information >>

S-Acetyl Glutathione
Complete

More information >>

Monolaurin or Monolauric Acid (MLA)​

More information

Monolaurin has demonstrated antibacterial, antiviral, and antimicrobial properties. Studies have also shown that Monolauric Acid can disintegrate the protective viral envelope, thereby preventing it from attaching and entering host cells, and ultimately kill the virus. MLA can also help the immune system recognize a pathogen by increasing immunogenicity creating an additional antigenic epitope that can be recognized by T-helper cells. This dramatically improves the immune response time and allows for a quicker resolution of infection.